Mobidiag, YouMed Collaborate
News Oct 05, 2016
Mobidiag Ltd has announced an agreement with YouMed Ltd, bespoke sales, marketing and distribution of high-quality medical technologies, regarding the Amplidiag® product line. Under this agreement, YouMed becomes an agent for commercialization in UK of Amplidiag® product line, in vitro diagnostic tests and compatible system for the detection of gastrointestinal infections.
“For the past months, we have been extending significantly our European distribution network. Making our Amplidiag product line available in the UK was definitely our next strategic step. Besides being clearly a high-value market, I strongly believe that our Amplidiag suite can bring great benefits to UK’s healthcare professionals. With that in mind, we are happy to initiate our partnership with YouMed as our local agent to expand Mobidiag’s market reach and visibility in the UK” said Tuomas Tenkanen, CEO at Mobidiag.
“YouMed are proud and excited to be partnering with Mobidiag bringing their Amplidiag range of products to the UK healthcare market. There is an unmet need in the UK molecular diagnostic market for accurate, reliable testing for Gastro-intestinal pathogens. We are confident the Mobidiag assays and systems can have a positive impact on the management of patients suffering from these infections” said Christopher Brain, Managing Director at YouMed Ltd.
The agreement is effective immediately and covers all Amplidiag® IVD tests (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and upcoming Amplidiag® Viral GE) as well as the upcoming Amplidiag® Easy system.
Adults with a first-degree relative with Alzheimer's disease perform more poorly on online paired-learning tasks than adults without such a family history, and this impairment appears to be exacerbated by having diabetes or a genetic variation in the apolipoprotein E (APOE) gene linked to the disease.READ MORE